Neurocrine Biosciences Inc

MASSACHUSETTS FINANCIAL SERVICES CO /MA/ NBIX

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/22/2026

Shares

126,341

Value ($000)

17,919

Weight

0.0%

2019 Q3 - 2025 Q4 (26 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/22/2026	17,919	0.0%	126,341	12/31/2025
2025 Q3	10/29/2025	19,198	0.0%	136,756	9/30/2025
2025 Q2	8/8/2025	22,657	0.0%	180,259	6/30/2025
2025 Q1	5/2/2025	16,663	0.0%	150,661	3/31/2025
2024 Q4	2/12/2025	20,520	0.0%	150,331	12/31/2024
2024 Q3	11/12/2024	18,787	0.0%	163,054	9/30/2024
2024 Q2	8/9/2024	21,474	0.0%	155,985	6/30/2024
2024 Q1	5/14/2024	20,946	0.0%	151,873	3/31/2024
2023 Q4	2/8/2024	23,160	0.0%	175,777	12/31/2023
2023 Q3	11/8/2023	19,790	0.0%	175,910	9/30/2023
2023 Q2	8/9/2023	16,593	0.0%	175,959	6/30/2023
2023 Q1	5/10/2023	17,032	0.0%	168,264	3/31/2023
2022 Q4	2/13/2023	21,620	0.0%	181,015	12/31/2022
2022 Q3	11/9/2022	19,165	0.0%	180,441	9/30/2022
2022 Q2	8/9/2022	21,010	0.0%	215,535	6/30/2022
2022 Q1	5/11/2022	20,353	0.0%	217,099	3/31/2022
2021 Q4	2/10/2022	17,983	0.0%	211,139	12/31/2021
2021 Q3	11/10/2021	17,407	0.0%	181,493	9/30/2021
2021 Q2	8/13/2021	13,949	0.0%	143,328	6/30/2021
2021 Q1	5/13/2021	13,979	0.0%	143,747	3/31/2021
2020 Q4	5/12/2021	14,101	0.0%	147,120	12/31/2020
2020 Q3	11/12/2020	10,898	0.0%	113,335	9/30/2020
2020 Q2	11/20/2020	14,161	0.0%	116,077	6/30/2020
2020 Q1	11/20/2020	11,189	0.0%	129,282	3/31/2020
2019 Q4	11/25/2020	14,213	0.0%	132,226	12/31/2019
2019 Q3	11/20/2020	11,911	0.0%	132,185	9/30/2019